Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Theravex Total Oral Care is a non-pharmaceutical oral care product developed by Biointelligent Technology Systems, a Spanish biotechnology company. Classified as a medical device and tissue nutrient-based therapy, it utilizes patented Bone Bioactive Liquid (BBL) technology. The formulation consists of a bioactive saline solution containing calcium chloride and magnesium chloride, engineered with a net negative charge to attract progenitor stem cells to injured oral tissues. The product promotes tissue regeneration and wound healing by optimizing wound hydration, enhancing intercellular communication, stabilizing the pH environment, and moderating inflammatory factors. It is primarily indicated for post-operative care following dental procedures such as tooth extractions and implant surgeries, as well as for managing periodontal diseases and oral mucosa pathologies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Theravex Total Oral Care.